People
PhaseV receives three industry honours for AI in clinical development
7 November 2025 - PhaseV, a developer of advanced AI/ML solutions to optimise clinical development, said on Thursday that it has received three 2025 industry honours.The company was named to CB Insigh...
Oxford Nanopore and bioMérieux introduce AmPORE-TB for rapid tuberculosis resistance characterisation
5 November 2025 - French diagnostics company bioMérieux (Euronext Paris:BIM) and UK-based molecular sensing technology company Oxford Nanopore Technologies (LON:ONT) on Wednesday announced the ...
Galapagos plans to wind down cell therapy business following strategic review
21 October 2025 - Belgian biotechnology company Galapagos NV (Euronext Brussels:GLPG) (NASDAQ:GLPG) on Tuesday announced its intention to wind down its cell therapy business following a comprehensive ...
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
16 October 2025 - Sebela Women's Health Inc, part of US pharmaceutical company Sebela Pharmaceuticals, announced on Wednesday that its MIUDELLA Hormone-Free Copper Intrauterine System (IUS) has b...
Revelation Pharma acquires Acacia Apothecary & Wellness
10 October 2025 - Revelation Pharma, a US-based national network of 503A and 503B compounding pharmacies, announced on Thursday its acquisition of Acacia Apothecary & Wellness, a compounding pharm...
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
9 October 2025 - US-based global healthcare company Viatris Inc (Nasdaq:VTRS) announced on Wednesday that it has been named to Forbes' list of World's Best Employers 2025.This is the fifth y...